Paronychia Treatment Market Research Report - Global Forecast till 2027

Paronychia Treatment Market Information: By Type (Acute Paronychia, Chronic Paronychia, Candidal Paronychia) Application (Mupirocin Ointment, Fusidic Acid Ointment, Dicloxacillin) End User (Hospitals & Clinics, Dermatology Center) - Forecast till 2027

ID: MRFR/Pharma/1184-HCR | February 2021 | Region: Global | 80 pages

Please note that the assessment period of report has been updated from 2017–2023 to 2020-2027. Cordially fill Sample form for updated data.

Market Scenario


The global market for paronychia treatment is one of the steady growing markets. Paronychia usually happens when the skin around an individual's nail is irritated or harmed. Paronychia is a soft tissue infection of the skin around the fingernails and toenails. Bacteria which cause this type of infection are known as Candida. The infection begins as cellulitis but may progress to a definite abscess.

Companies are continuously inventing new products to capture the market globally. Thus, major players invest more in research and development activity, in order to lead the global market. Market players are focusing more on collaboration and acquisition in order to develop the product portfolio, which help them to lead the market and capture maximum share. Market players are continuously working to minimize the gap between demand and supply of quality treatment in order to maximize profit.

The global paronychia treatment market is expected to grow at a CAGR of 11.7% during the forecast period 2017-2023.


 


Intended Audience



  • Pharmaceutical manufacturers & Suppliers

  • Paronychia treatment products manufacturers & Suppliers

  • Pharmaceutical and biotechnology companies

  • Hospitals and diagnostic centers

  • Clinics

  • Academic research institutes

  • Government institutes


Figure: Global Paronychia treatment Market, By Region Market Share, 2016 (%) Paronychia treatment Market


               Sources: Annual reports, Press release, White paper, Company presentation


Segmentations


The global paronychia treatment market is segmented on the basis of type, application, and end user.


On the basis of the type, it is segmented into acute paronychia, chronic paronychia, candidal paronychia, pyogenic paronychia, and others.  


On the basis of the application, it is segmented into mupirocin ointment, fusidic acid ointment, gentamicin ointment, dicloxacillin and others.


On the basis of the end user, it is segmented into hospitals & clinics, dermatology center, and others.


Regional Analysis


The Americas account for a major share in the global paronychia treatment market owing to the increasing prevalence of acute paronychia, chronic paronychia, candidal paronychia, and pyogenic paronychia. Moreover, well-developed technology, increasing government support for research & development, high healthcare expenditure, and changing lifestyle have fuelled the growth of the Americas paronychia treatment market. Additionally, the concentration of major players in this region is likely to fuel the growth of the market during the forecasted period.


Europe holds the second largest paronychia treatment market, which is followed by Asia Pacific. Availability of funds for research & development and strong government support, drive the market growth. For instance, countries like Germany and France are increasing investment in the healthcare domain. Most of the players belong to this region and are constantly investing more into research and development for introducing quality treatment. There is a huge demand of quality treatment from the emerging market. Thus, they encash the opportunity and maximize the market share by exporting better treatment option to the developing countries of Asia Pacific region.


Asia Pacific is the fastest growing paronychia treatment market owing to the increasing healthcare awareness, rapidly developing economy and increasing government support. Moreover, increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. Government of the developing countries in this region are more focused on quality treatment in order to improve the living standard of their citizen. Moreover, the increasing patient population create the huge demand for the better treatment.


On the other hand, the Middle East & Africa holds the least share of the market due to poor political conditions in Africa and limited availability of funds and availability of medical facilities. The Middle East is leading the Middle East & African paronychia treatment due to the presence of well-developed countries like Kuwait, Qatar, Oman, and South Arabia. Whereas, Africa region is expecting a healthy growth due to the presence of a huge opportunity for the development of the market.


Key Players


Some of the key players in this market are GlaxoSmithKline plc (U.K), Glenmark Generics Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly Company (U.S.), Jonakayem Pharma Formulation Pvt. Ltd. (India), Fougera Pharmaceuticals Inc. (U.S.), Taro Pharmaceutical Industries Ltd. (U.S.), Perrigo New York, Inc. (U.S.) and others.


 


Research Methodology


Global Paronychia treatment Market Sources: Annual reports, Press release, White paper, and Company presentation



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant value
  CAGR   11.7%
  Base Year   2017
  Forecast Period   2027
  Historical Data   2016
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factor and Trends
  Segments Covered   Type, Application, and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   GlaxoSmithKline plc (U.K), Glenmark Generics Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly Company (U.S.), Jonakayem Pharma Formulation Pvt. Ltd. (India), Fougera Pharmaceuticals Inc. (U.S.), Taro Pharmaceutical Industries Ltd. (U.S.), Perrigo New York, Inc. (U.S.)
  Key Market Opportunities   New products
  Key Market Drivers

  • Research & development
  • Strong government support


  • Table of Content

    1. Report Prologue

    2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    6. Global Paronychia Treatment Market, by Types

    6.1 Introduction

    6.2 Acute Paronychia

    6.2.1 Market Estimates & Forecast, 2020-2027

    6.3 Chronic Paronychia

    6.3.1 Market Estimates & Forecast, 2020-2027

    6.4 Candidal Paronychia

    6.4.1 Market Estimates & Forecast, 2020-2027

    6.5 Pyogenic Paronychia

    6.5.1 Market Estimates & Forecast, 2020-2027

    6.6 Others

    6.6.1 Market Estimates & Forecast, 2020-2027

    7. Global Paronychia Treatment Market, by Application

    7.1 Introduction

    7.2 Mupirocin Ointment

    7.2.1 Market Estimates & Forecast, 2020-2027

    7.3 Fusidic Acid Ointment

    7.3.1 Market Estimates & Forecast, 2020-2027

    7.4 Gentamicin Ointment

    7.4.1 Market Estimates & Forecast, 2020-2027

    7.5 Dicloxacillin

    7.5.1 Market Estimates & Forecast, 2020-2027

    7.6 Others

    7.6.1 Market Estimates & Forecast, 2020-2027

    8. Global Paronychia Treatment Market, by End User

    8.1 Introduction

    8.2 Hospitals & Clinics

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Dermatology Center

    8.3.1 Market Estimates & Forecast, 2020-2027

    8.4 Others

    8.4.1 Market Estimates & Forecast, 2020-2027

    9. Global Paronychia Treatment Market, by Region

    9.1 Introduction

    9.2 Americas

    9.2.1 North America

    9.2.1.1 U.S.

    9.2.1.2 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 U.K

    9.3.1.4 Italy

    9.3.1.5 Spain

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 Republic of Korea

    9.4.6 Rest of Asia Pacific

    9.5 The Middle East & Africa

    9.5.1 United Arab Emirates

    9.5.2 Saudi Arabia

    9.5.3 Oman

    9.5.4 Kuwait

    9.5.5 Qatar

    9.5.6 Rest of the Middle East & Africa

    10 Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    10.3.1 Key Developments

    11 Company Profiles

    11.1 GlaxoSmithKline plc

    11.1.1 Company Overview

    11.1.2 Product Overview

    11.1.3 Financials

    11.1.4 SWOT Analysis

    11.2 Glenmark Generics Ltd.

    11.2.1 Company Overview

    11.2.2 Product Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 Teva Pharmaceutical Industries Ltd.

    11.3.1 Company Overview

    11.3.2 Product Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Eli Lilly Company

    11.4.1 Company Overview

    11.4.2 Product/Business Segment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 Jonakayem Pharma Formulation Pvt. Ltd.

    11.5.1 Company Overview

    11.5.2 Product Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.6 Fougera Pharmaceuticals Inc.

    11.6.1 Company Overview

    11.6.2 Product Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.7 Taro Pharmaceutical Industries Ltd.

    11.7.1 Overview

    11.7.2 Product Overview

    11.7.3 Financials

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 Others

    12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s View Point

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Prediction of Pharmaceutical Industry

    13 Appendix


    LIST OF TABLES

    Table 1 Paronychia Treatment Industry Synopsis, 2020-2027

    Table 2 Global Paronychia Treatment Market Estimates and Forecast, 2020-2027, (USD Million)

    Table 3 Global Paronychia Treatment Market by Region, 2020-2027, (USD Million)

    Table 4 Global Paronychia Treatment Market by Types, 2020-2027, (USD Million)

    Table 5 Global Paronychia Treatment Market by Application, 2020-2027, (USD Million)

    Table 6 Global Paronychia Treatment Market by End Users, 2020-2027, (USD Million)

    Table 7 North America Paronychia Treatment Market by Types, 2020-2027, (USD Million)

    Table 8 North America Paronychia Treatment Market by Application, 2020-2027, (USD Million)

    Table 9 North America Paronychia Treatment Market by End Users, 2020-2027, (USD Million)

    Table 10 US Paronychia Treatment Market by Types, 2020-2027, (USD Million)

    Table 11 US Paronychia Treatment Market by Application, 2020-2027, (USD Million)

    Table 12 US Paronychia Treatment Market by End Users, 2020-2027, (USD Million)

    Table 13 Canada Paronychia Treatment Market by Types, 2020-2027, (USD Million)

    Table 14 Canada Paronychia Treatment Market by Application, 2020-2027, (USD Million)

    Table 15 Canada Paronychia Treatment Market by End Users, 2020-2027, (USD Million)

    Table 16 South America Paronychia Treatment Market by Types, 2020-2027, (USD Million)

    Table 17 South America Paronychia Treatment Market by Application, 2020-2027, (USD Million)

    Table 18 South America Paronychia Treatment Market by End Users, 2020-2027, (USD Million)

    Table 19 Europe Paronychia Treatment Market by Types, 2020-2027, (USD Million)

    Table 20 Europe Paronychia Treatment Market by Application, 2020-2027, (USD Million)

    Table 21 Europe Paronychia Treatment Market by End Users, 2020-2027, (USD Million)

    Table 22 Western Europe Paronychia Treatment Market by Types, 2020-2027, (USD Million)

    Table 23 Western Europe Paronychia Treatment Market by Application, 2020-2027, (USD Million)

    Table 24 Western Europe Paronychia Treatment Market by End Users, 2020-2027, (USD Million)

    Table 25 Eastern Europe Paronychia Treatment Market by Types, 2020-2027, (USD Million)

    Table 26 Eastern Europe Paronychia Treatment Market by Application, 2020-2027, (USD Million)

    Table 27 Eastern Europe Paronychia Treatment Market by End Users, 2020-2027, (USD Million)

    Table 28 Asia Pacific Paronychia Treatment Market by Types, 2020-2027, (USD Million)

    Table 29 Asia Pacific Paronychia Treatment Market by Application, 2020-2027, (USD Million)

    Table 30 Asia Pacific Paronychia Treatment Market by End Users, 2020-2027, (USD Million)

    Table 31 Middle East & Africa Paronychia Treatment Market by Types, 2020-2027, (USD Million)

    Table 32 Middle East & Africa Paronychia Treatment Market by Application, 2020-2027, (USD Million)

    Table 33 Middle East & Africa Paronychia Treatment Market by End Users, 2020-2027, (USD Million)
    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Paronychia Treatment Market

    Figure 3 Segmentation Market Dynamics for Paronychia Treatment Market

    Figure 4 Global Paronychia Treatment Market Share, by Types 2020

    Figure 5 Global Paronychia Treatment Market Share, by Application 2020

    Figure 6 Global Paronychia Treatment Market Share, by End Users, 2020

    Figure 7 Global Paronychia Treatment Market Share, by Region, 2020

    Figure 8 Americas Paronychia Treatment Market Share, by Country, 2020

    Figure 9 Europe Paronychia Treatment Market Share, by Country, 2020

    Figure 10 Asia Pacific Paronychia Treatment Market Share, by Country, 2020

    Figure 11 Middle East & Africa Paronychia Treatment Market Share, by Country, 2020

    Figure 12 Global Paronychia Treatment Market: Company Share Analysis, 2020 (%)

    Figure 13 GlaxoSmithKline plc: Key Financials

    Figure 14 GlaxoSmithKline plc: Segmental Revenue

    Figure 15 GlaxoSmithKline plc: Geographical Revenue

    Figure 16 Glenmark Generics Ltd: Key Financials

    Figure 17 Glenmark Generics Ltd: Segmental Revenue

    Figure 18 Glenmark Generics Ltd: Geographical Revenue

    Figure 19 Teva Pharmaceutical Industries Ltd: Key Financials

    Figure 20 Teva Pharmaceutical Industries Ltd: Segmental Revenue

    Figure 21 Teva Pharmaceutical Industries Ltd: Geographical Revenue

    Figure 22 Eli Lilly Company: Key Financials

    Figure 23 Eli Lilly Company: Segmental Revenue

    Figure 24 Eli Lilly Company: Geographical Revenue

    Figure 25 Jonakayem Pharma Formulation Pvt. Ltd: Key Financials

    Figure 26 Jonakayem Pharma Formulation Pvt. Ltd: Segmental Revenue

    Figure 27 Jonakayem Pharma Formulation Pvt. Ltd: Geographical Revenue

    Figure 28 Fougera Pharmaceuticals Inc.: Key Financials

    Figure 29 Fougera Pharmaceuticals Inc.: Segmental Revenue

    Figure 30 Fougera Pharmaceuticals Inc.: Geographical Revenue

    Figure 31 Taro Pharmaceutical Industries Ltd.: Key Financials

    Figure 32 Taro Pharmaceutical Industries Ltd.: Segmental Revenue

    Figure 33 Taro Pharmaceutical Industries Ltd.: Geographical Revenue